| Prevalence of venous thromboembolism in critically ill COVID-19 patients: systematic review and meta-analysis MFH Mohamed, SD Al-Shokri, KM Shunnar, SF Mohamed, MS Najim, ... Frontiers in Cardiovascular Medicine 7, 598846, 2021 | 45 | 2021 |
| Low vitamin D and cardiovascular risk factors in males and females from a sunny, rich country A El-Menyar, A Rahil, K Dousa, W Ibrahim, T Ibrahim, R Khalifa, ... The open cardiovascular medicine journal 6, 76, 2012 | 33 | 2012 |
| Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors KM Dousa, SG Kurz, MA Taracila, T Bonfield, CR Bethel, MD Barnes, ... Antimicrobial agents and chemotherapy 64 (8), 10.1128/aac. 00098-20, 2020 | 32 | 2020 |
| Disseminated tuberculosis among adult patients admitted to Hamad general hospital, Qatar: A five year hospital based study FY Khan, K Dosa, A Fuad, W Ibrahim, A Alaini, L Osman, M Albadri, ... Mycobact Dis 6 (212), 2161-1068, 2016 | 32 | 2016 |
| Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar MA Sid Ahmed, H Abdel Hadi, AAI Hassan, S Abu Jarir, MA Al-Maslamani, ... Journal of antimicrobial chemotherapy 74 (12), 3497-3504, 2019 | 31 | 2019 |
| Impact of diabetes mellitus on the presentation and response to treatment of adults with pulmonary tuberculosis in Qatar KM Dousa, A Hamad, M Albirair, H Al Soub, AN Elzouki, MI Alwakeel, ... Open forum infectious diseases 6 (1), ofy335, 2019 | 23 | 2019 |
| “One-Two Punch”: Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes DC Nguyen, KM Dousa, SG Kurz, ST Brown, G Drusano, SM Holland, ... Clinical Infectious Diseases 73 (8), 1532-1536, 2021 | 20 | 2021 |
| Drug-resistant tuberculosis: a glance at progress and global challenges KM Dousa, SG Kurz, CM Bark, RA Bonomo, JJ Furin Infectious Disease Clinics 34 (4), 863-886, 2020 | 17 | 2020 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid contamination of surfaces on a coronavirus disease 2019 (COVID-19) ward and intensive care unit SN Redmond, KM Dousa, LD Jones, DF Li, JL Cadnum, ME Navas, ... Infection Control & Hospital Epidemiology 42 (2), 215-217, 2021 | 15 | 2021 |
| SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: implications for prophylaxis KM Dousa, SS Malavade, J Furin, B Gripshover, M Hatszegi, L Hojat, ... IDCases 20, e00778, 2020 | 14 | 2020 |
| Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection KM Dousa, A Babiker, D Van Aartsen, N Shah, RA Bonomo, JL Johnson, ... Open Forum Infectious Diseases 5 (7), ofy168, 2018 | 14 | 2018 |
| Inhibiting Mycobacterium abscessus cell wall synthesis: using a novel diazabicyclooctane β-lactamase inhibitor to augment β-lactam action KM Dousa, DC Nguyen, SG Kurz, MA Taracila, CR Bethel, W Schinabeck, ... Mbio 13 (1), e03529-21, 2022 | 11 | 2022 |
| Epidemiology and the changing face of HIV infection in Qatar H Al Soub, AL Al-khal, M Al Maslamani, K Dousa, A Ahmed, A Fabella Infectious Diseases in Clinical Practice 26 (4), 220-223, 2018 | 11 | 2018 |
| Renal infarction in vascular Ehlers–Danlos syndrome masquerading as pyelonephritis KM Dousa, K Khan, B Alencherry, L Deng, RA Salata Clinical Case Reports 6 (8), 1478, 2018 | 5 | 2018 |
| A 40-year-old female with Mycobacterium abscessus successfully treated with a dual beta-lactam combination N Moguillansky, K DeSear, KM Dousa Cureus 15 (6), 2023 | 4 | 2023 |
| Progressive and disseminated histoplasma infection and hemophagocytic lymphohistiocytosis in an immunocompetent adult KM Dousa, A De la Hoz, E Church, T Onger, F Perez, E Saade Clinical Case Reports 7 (5), 913, 2019 | 4 | 2019 |
| Eradicating Pulmonary Mycobacterium abscessus: The Promise of Dual β-Lactam Therapy B Alahmdi, KM Dousa, SG Kurz, A Kaufman, RA Bonomo, S Taimur Open Forum Infectious Diseases 10 (6), ofad312, 2023 | 2 | 2023 |
| 1390. Durlobactam, a Diazabicyclooctane (DBO) β-lactamase Inhibitor (BLI), Inhibits BlaC and Peptidoglycan (PG) Transpeptidases of Mycobacterium tuberculosis (Mtb): A Novel … D Nguyen, C Bethel, MA Taracilla, Q Li, KM Dousa, SG Kurz, L Nguyen, ... Open Forum Infectious Diseases 8 (Supplement_1), S780-S780, 2021 | 2 | 2021 |
| Mycobacterial tenosynovitis after sea urchin spine injury in an immunocompromised patient CR Vargas, A Kanwar, KM Dousa, MJ Skalweit, D Rowe, J Gatherwright Open Forum Infectious Diseases 5 (11), ofy285, 2018 | 2 | 2018 |
| Tailoring morning reports to an internal medicine residency in Qatar KMA Dousa, M Muneer, A Rahil, A Al-Mohammed, D AlMohanadi, ... Journal of Graduate Medical Education 6 (4), 801-804, 2014 | 2 | 2014 |
Mouhand F.H. MohamedBrown UniversityEmail verificata su brown.edu
